A critical review of recent clinical practice guidelines on the diagnosis and treatment of non-neurogenic male lower urinary tract symptoms

Authors

  • Michael Erlano Chua St. Luke's Medical Center-Institute of Urology
  • Jonathan Mendoza St. Luke's College of Medicine- Preventive and Community Medicine Department
  • Manuel See IV Institute of Urology- St. Luke's Medical Center
  • Ednalyn Esmena Comprehensive Pelvic Floor Center- St. Luke's Medical Center
  • Dean Aguila Clinical Information Management Service- St. Luke's Medical Center
  • Jan Michael Silangcruz St. Luke's Medical Center- Institute of Urology
  • Buenaventura Jose Reyes
  • Saturnino Luna Jr St. Luke's Medical Center- Institute of Urology
  • Marcelino Morales Jr National Kidney And Transplant Institute- Department of Urology

DOI:

https://doi.org/10.5489/cuaj.2424

Abstract

Introduction: We provide an overview of the quality of recent clinical clinical practice guidelines (CPGs) for non-neurogenic male lower urinary tract symptoms (LUTS) and summarize the recommendations for their diagnosis, assessment, and treatment.

Methods: We systematically searched recent (2008–2013) CPGs for non-neurogenic male LUTS. Eligible CPGs were assessed and appraised using Appraisal of Guidelines, Research and Evaluation II (AGREE II) tool by a CPG-appraisal group. The appraisal scores for each guideline were summarized according to each domain and in total. A recommendation summary was made across the guidelines for diagnostics, conservative management, medical, minimally invasive therapy, and surgical management.

Results: A total of 8 guidelines were considered. According to AGREE II appraisal of guidelines, the National Institute for Health and Clinical Excellence (NICE), American Urological Association (AUA) and European Association of Urology (EAU) consistently scored high on the guideline domains assessed. Recommendations on diagnostics, conservative management, medical, and surgical management were consistent among the top 3 guidelines. However, we noted a discrepancy in recommending minimally invasive therapy as an alternative management of moderate to severe or bothersome non-neurogenic male LUTS secondary to benign prostatic enlargement (BPE); the NICE guideline, in particular, does not recommend using minimally invasive therapy.

Conclusion: The quality of recent CPGs on non-neurogenic male LUTS was appraised and summarized. The guidelines from NICE, AUA and EAU were considered highly compliant to the AGREE II proposition for guideline formation and development.

Downloads

Download data is not yet available.

Author Biographies

Michael Erlano Chua, St. Luke's Medical Center-Institute of Urology

Institute of Urology- Urologist staff

Jonathan Mendoza, St. Luke's College of Medicine- Preventive and Community Medicine Department

Research Fellow

Manuel See IV, Institute of Urology- St. Luke's Medical Center

Urology Staff

Ednalyn Esmena, Comprehensive Pelvic Floor Center- St. Luke's Medical Center

Urology Nurse

Dean Aguila, Clinical Information Management Service- St. Luke's Medical Center

Senior Research Assistant

Jan Michael Silangcruz, St. Luke's Medical Center- Institute of Urology

Urology Resident

Saturnino Luna Jr, St. Luke's Medical Center- Institute of Urology

Quality Management Officer

Marcelino Morales Jr, National Kidney And Transplant Institute- Department of Urology

Assistant Chairman

Downloads

Published

2015-07-17

How to Cite

Chua, M. E., Mendoza, J., See IV, M., Esmena, E., Aguila, D., Silangcruz, J. M., Reyes, B. J., Luna Jr, S., & Morales Jr, M. (2015). A critical review of recent clinical practice guidelines on the diagnosis and treatment of non-neurogenic male lower urinary tract symptoms. Canadian Urological Association Journal, 9(7-8), E463–70. https://doi.org/10.5489/cuaj.2424